AAAAAA
Results:
1-20
|
Results: 20
Authors:
Wu, AHB
Citation: Ahb. Wu, Analytical issues affecting the clinical performance of cardiac troponin assays, AM HEART MG, 2001, pp. 1-12
Authors:
McDonough, JL
Labugger, R
Van Eyk, JE
Citation: Jl. Mcdonough et al., Prepare to meet your markers: Making the most out of troponin I degradation, AM HEART MG, 2001, pp. 13-21
Authors:
Yeo, KTJ
Quinn-Hall, KS
Bateman, SW
Fischer, GA
Wieczorek, S
Wu, AHB
Citation: Ktj. Yeo et al., Functional sensitivity of cardiac troponin assays and its implications forrisk stratification for patients with acute coronary syndromes, AM HEART MG, 2001, pp. 23-29
Authors:
Apple, FS
Adams, JE
Wu, AHB
Jaffe, AS
Citation: Fs. Apple et al., Report on a survey of analytical and clinical characteristics of commercial cardiac troponin assays, AM HEART MG, 2001, pp. 31-34
Authors:
Valdes, R
Jortani, SA
Citation: R. Valdes et Sa. Jortani, The current assessment of qualitative and quantitative point-of-care testing of cardiac markers, AM HEART MG, 2001, pp. 35-46
Authors:
Adams, JE
Miracle, VA
Citation: Je. Adams et Va. Miracle, Acute coronary syndromes: Pathophysiology, clinical presentation, and initial diagnostic strategies, AM HEART MG, 2001, pp. 47-62
Authors:
Jaffe, AS
Citation: As. Jaffe, WHO criteria: Where do we go from here?, AM HEART MG, 2001, pp. 63-74
Authors:
Jesse, RL
Kontos, MC
Citation: Rl. Jesse et Mc. Kontos, An integrated diagnostic approach to the patient with chest pain, AM HEART MG, 2001, pp. 75-94
Authors:
Hudson, MP
Goldmann, BU
Ohman, EM
Citation: Mp. Hudson et al., The use of cardiac markers for therapeutic decisions in acute coronary syndromes, AM HEART MG, 2001, pp. 95-104
Authors:
Grundy, DA
Gibler, WB
Citation: Da. Grundy et Wb. Gibler, The evaluation of acute coronary syndrome in the emergency department: Theimpact of cardiac biomarkers and ST-segment trend monitoring, AM HEART MG, 2001, pp. 105-116
Authors:
Giannitsis, E
Weidtmann, B
Muller-Bardorff, M
Frey, N
Katus, HA
Citation: E. Giannitsis et al., Cardiac troponin T in coronary artery disease: Where do we stand?, AM HEART MG, 2001, pp. 117-130
Authors:
Fromm, R
Roberts, R
Citation: R. Fromm et R. Roberts, Creatine kinase: A marker for the early diagnosis of acute myocardial infarction, AM HEART MG, 2001, pp. 131-137
Authors:
Glatz, JFC
Hermens, WT
Citation: Jfc. Glatz et Wt. Hermens, Fatty acid binding protein as a plasma marker for the early assessment of individuals with acute coronary syndromes, AM HEART MG, 2001, pp. 139-158
Authors:
Holvoet, P
Van de Werf, F
Vanhaecke, J
Collen, D
Citation: P. Holvoet et al., Oxidized low-density lipoprotein and malondialdehyde-modified low-density lipoprotein: Markers of coronary artery disease, AM HEART MG, 2001, pp. 159-171
Authors:
Ridker, PM
Citation: Pm. Ridker, High-sensitivity C-reactive protein: A novel inflammatory marker for predicting risk of coronary artery disease, AM HEART MG, 2001, pp. 173-183
Authors:
Daniel, GK
Gupta, R
Gillespie, J
Felten, R
Cise, L
Sturdevant, K
Ritchie, ME
Citation: Gk. Daniel et al., Nuclear factor kappa B: A marker of coronary artery disease activity?, AM HEART MG, 2001, pp. 185-192
Authors:
Adams, JE
Citation: Je. Adams, The use of troponins to detect cardiac injury after cardiac and noncardiacsurgery, AM HEART MG, 2001, pp. 193-202
Authors:
Apple, FS
Citation: Fs. Apple, The role of cardiac troponin testing in renal disease, AM HEART MG, 2001, pp. 203-209
Authors:
Herman, EH
Ferrans, VJ
Citation: Eh. Herman et Vj. Ferrans, The use of cardiac biomarkers for the detection of drug-induced myocardialdamage, AM HEART MG, 2001, pp. 211-234
The utility of brain natriuretic peptides in patients with heart failure and coronary artery disease
Authors:
Mair, J
Citation: J. Mair, The utility of brain natriuretic peptides in patients with heart failure and coronary artery disease, AM HEART MG, 2001, pp. 235-262
Risultati:
1-20
|